These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. QUAD routes out inferior drugs. Can Hosp; 1973 May; 50(5):58-9. PubMed ID: 4779804 [No Abstract] [Full Text] [Related]
4. [The birth of new drugs]. Petrányi G Orv Hetil; 1968 May; 109(21):Suppl:1-6. PubMed ID: 5720715 [No Abstract] [Full Text] [Related]
5. Clinical investigation of new drugs. Pugsley LI Appl Ther; 1966 Mar; 8(3):243-9. PubMed ID: 5324973 [No Abstract] [Full Text] [Related]
6. [Guidelines for introducing new drugs for medical use in Poland and control of their quality]. Danysz A Pol Tyg Lek; 1984 Dec 17-31; 39(51-52):1673-4. PubMed ID: 6522321 [No Abstract] [Full Text] [Related]
8. Introduction of direct-to-consumer advertising of prescription drugs in Canada: an opinion survey on regulatory policy. Mintzes B; Barer M; Lexchin J; Bassett KL Res Social Adm Pharm; 2005 Jun; 1(2):310-30. PubMed ID: 17138480 [TBL] [Abstract][Full Text] [Related]
9. [Proposals for the legal control of the testing and introduction of drugs based on a comparison of drug laws in other countries]. Burow W; Lüllmann H Schriftenr Geb Off Gesundheitswes; 1971; 31():1-64. PubMed ID: 5153578 [No Abstract] [Full Text] [Related]
10. Adopting orphan drugs: Congress tries to encourage new remedies for rare diseases. Wallis C Time; 1982 Oct; 120(15):76, 79. PubMed ID: 10317248 [No Abstract] [Full Text] [Related]
11. Letter: Introduction of "new" drugs. Morrison AB Can Med Assoc J; 1975 Jun; 112(11):1285, 1289. PubMed ID: 1125900 [No Abstract] [Full Text] [Related]
12. [The new norms decreed by the legislative dirrective 91-93 CCE]. Neri M; Palazzo S Boll Chim Farm; 1998 Feb; 137(2):31-4. PubMed ID: 9595832 [TBL] [Abstract][Full Text] [Related]
13. Human and veterinary drugs: good manufacturing practices and proposed exemptions for certain OTC products. Fed Regist; 1978 Sep; 43(190 Pt 2):45013-89. PubMed ID: 10316700 [No Abstract] [Full Text] [Related]
14. [Harmful effects of drugs. Liability of the manufacturers against insurance claims for damages]. Dahl B Ugeskr Laeger; 1984 Sep; 146(36):2726-8. PubMed ID: 6515894 [No Abstract] [Full Text] [Related]
15. [Liability for drug-related damage by the pharmaceutical industry and the physician]. Dahse G Beitr Gerichtl Med; 1982; 40():21-2. PubMed ID: 7165639 [No Abstract] [Full Text] [Related]
16. [Preclinical documentation for the registration of drugs]. Cantone A Boll Chim Farm; 1971 Oct; 110(10):579-81. PubMed ID: 5143356 [No Abstract] [Full Text] [Related]
17. Counterfeit drugs: implications for health. ten Ham M Adverse Drug React Toxicol Rev; 1992; 11(1):59-65. PubMed ID: 1606284 [No Abstract] [Full Text] [Related]
19. The Food and Drugs Act and quality assurance of pharmaceutical products. Allmark MG Med Serv J Can; 1967 Mar; 23(3):210-6. PubMed ID: 6056366 [No Abstract] [Full Text] [Related]
20. [Detection of side effects. 2: Responsibilities of the pharmaceutical industry, drug commissions, the Federal Health Office and international organizations]. Gleiter CH; Bieck PR Fortschr Med; 1991 Jul; 109(21):429-31. PubMed ID: 1916572 [No Abstract] [Full Text] [Related] [Next] [New Search]